Publications (59) Publications de MANUEL GÓMEZ GUZMÁN

2024

  1. Differing contributions of the gut microbiota to the blood pressure lowering effects induced by first-line antihypertensive drugs

    British Journal of Pharmacology

  2. The importance of COVID-19 vaccination during lactation

    INFECTIOUS DISEASES NOW, Vol. 54, Núm. 1

2023

  1. Community pharmacy is the key to improving vitamin D levels

    Exploratory Research in Clinical and Social Pharmacy, Vol. 9

  2. Innovación docente en farmacología: relato de nuestra experiencia en el aprendizaje basado en artefactos (ABA)

    Actualidad en farmacología y terapéutica, Vol. 21, Núm. 2, pp. 150-163

  3. Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats

    Biomedicine and Pharmacotherapy, Vol. 158

  4. Principales barreras para la participación de pacientes y farmacéuticos en investigaciones realizadas en la farmacia comunitaria: (Proyecto INFACO: Investigación en Farmacias Comunitarias)

    Ars pharmaceutica, Vol. 64, Núm. 1, pp. 12-12

  5. Protective effect of microbiota-derived short chain fatty acids on vascular dysfunction in mice with systemic lupus erythematosus induced by toll like receptor 7 activation

    Pharmacological Research, Vol. 198

2022

  1. Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation

    European Journal of Medicinal Chemistry, Vol. 230

  2. Herbario virtual online colaborativo en las asignaturas de Farmacognosia y Fitoterapia y Nutraceúticos y Fitoterapia

    La necesidad de la transformación social desde la innovación docente y educativa (Aula Magna), pp. 312-328

  3. Narrativa sanitaria como herramienta docente aplicada para incentivar una comunidad universitaria comprometida con los ODS

    Innovación educativa para el desarrollo sostenible, la economía y la empresa (Aula Magna), pp. 201-218

  4. Trimethylamine n-oxide promotes autoimmunity and a loss of vascular function in toll-like receptor 7-driven lupus mice

    Antioxidants, Vol. 11, Núm. 1

  5. Un nuevo camino en la Atención Farmacéutica: la idoneidad de la Evaluación Clínica Objetiva Estructurada

    Ars pharmaceutica, Vol. 63, Núm. 3, pp. 222-233

  6. Vasoconstrictor and Pressor Effects of Des-Aspartate-Angiotensin I in Rat

    Biomedicines, Vol. 10, Núm. 6

2021

  1. Changes in gut microbiota induced by doxycycline influence in vascular function and development of hypertension in doca-salt rats

    Nutrients, Vol. 13, Núm. 9

  2. Digital teams for pursuing excellence in online education

    EduLearn 21 Proceedings: 13th International Conference on Education and New Learning Technologies Online Conference. 5-6 July, 2021.

  3. Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus

    British Journal of Pharmacology, Vol. 178, Núm. 18, pp. 3708-3729

  4. Gut microbiota has a crucial role in the development of hypertension and vascular dysfunction in toll-like receptor 7-driven lupus autoimmunity

    Antioxidants, Vol. 10, Núm. 9

  5. Mycophenolate mediated remodeling of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rats

    Biomedicine and Pharmacotherapy, Vol. 135

  6. Nuevas tecnologías y apps en el laboratorio de plantas medicinales

    Conference proceedings. CIVINEDU 2021: 5th International Virtual Conference onEducational Research and Innovation

  7. Probiotics prevent hypertension in a murine model of systemic lupus erythematosus induced by toll-like receptor 7 activation

    Nutrients, Vol. 13, Núm. 8